Blood Transfusion Diagnostics Market Share

  • Report ID: 4481
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Blood Transfusion Diagnostics Market Share

APAC Market Statistics

The Asia Pacific blood transfusion diagnostics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. It is driven by aspects such as the rising need for blood transfusions, the developing healthcare infrastructure in the area, and the rising public awareness of the value of blood donation and testing. A considerable portion of the Asia Pacific blood transfusion diagnostics market is anticipated to increase in countries like China and India owing to their big populations and quickly growing healthcare infrastructure. Other countries in the area are also anticipated to develop as well due to factors such as the rise in hospital-based diagnostic labs and the desire for quick and precise blood tests.

North American Market Forecast

The North American blood transfusion diagnostics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. A higher number of road accidents taking place in the region is driving the market growth in North America. As of 2022, more than 6 million vehicle crashes took place in the United States. The growth is also attributed to the lack of blood during COVID-19, which in turn is propelling the requirement for blood donation. Since March 2020, the rate of blood donation dropped by about 10% and there has been about a 62% decrease in blood drives across colleges and schools.

Research Nester
Blood Transfusion Diagnostics Market Size

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4481
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease are the few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2023-2033.

The dearth of skilled technicians, exorbitant prices of tests and instruments, and shortage of infrastructure are the few factors that are likely to hamper the market growth.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc., and so on…

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user, and by region.

Blood screening is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying